MARKET

DXR

DXR

DAXOR CORP
NASDAQ
7.84
+0.08
+1.06%
After Hours: 8.24 +0.4 +5.10% 16:53 11/30 EST
OPEN
7.78
PREV CLOSE
7.76
HIGH
7.84
LOW
7.76
VOLUME
3.47K
TURNOVER
0
52 WEEK HIGH
13.13
52 WEEK LOW
7.11
MARKET CAP
37.57M
P/E (TTM)
9.13
1D
5D
1M
3M
1Y
5Y
DAXOR CORP: Current report
Press release · 2d ago
DAXOR CORP: Statement of changes in beneficial ownership of securities
Press release · 3d ago
Weekly Report: what happened at DXR last week (1120-1124)?
Weekly Report · 3d ago
DAXOR CORP: Statement of changes in beneficial ownership of securities
Press release · 6d ago
Weekly Report: what happened at DXR last week (1113-1117)?
Weekly Report · 11/20 10:05
DAXOR CORP: Statement of changes in beneficial ownership of securities
Press release · 11/13 14:28
Daxor Corporation Announces Presentation Of Data From Phase I NIH-Sponsored Trial At American Heart Association Annual Meeting
Benzinga · 11/13 13:03
Weekly Report: what happened at DXR last week (1106-1110)?
Weekly Report · 11/13 10:02
More
About DXR
Daxor Corporation is a blood volume measurement technology company, which is focused on blood volume testing innovation. The Company has developed and marketed the Blood Volume Analyzer (BVA-100), the diagnostic blood test cleared by the food and drug administration (FDA) to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000+ tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including significantly reducing mortality and readmissions in heart failure and critical care. It is also focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. It has several ongoing trials in the areas of heart failure treatment with support from the National Institutes of Health (NIH) and is under contract developing analyzers.

Webull offers Daxor Corporation stock information, including NASDAQ: DXR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXR stock methods without spending real money on the virtual paper trading platform.